27 January 2022 false No description of principal activity Taxfiler 2023.9.1 13876796business:PrivateLimitedCompanyLtd2022-01-272023-01-31 138767962022-01-26 138767962022-01-272023-01-31 13876796business:AuditExemptWithAccountantsReport2022-01-272023-01-31 13876796business:FilletedAccounts2022-01-272023-01-31 138767962023-01-31 13876796business:Director12022-01-272023-01-31 13876796business:RegisteredOffice2022-01-272023-01-31 138767962022-01-31 13876796core:AfterOneYear2023-01-31 13876796core:AfterOneYear2022-01-31 13876796core:ShareCapitalcore:PreviouslyStatedAmount2023-01-31 13876796core:ShareCapitalcore:PreviouslyStatedAmount2022-01-31 13876796core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-01-31 13876796core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-01-31 13876796core:PreviouslyStatedAmount2023-01-31 13876796core:PreviouslyStatedAmount2022-01-31 13876796business:SmallEntities2022-01-272023-01-31 13876796countries:EnglandWales2022-01-272023-01-31 13876796core:FurnitureFittings2022-01-272023-01-31 13876796core:ComputerEquipment2022-01-272023-01-31 13876796core:FurnitureFittings2022-01-26 13876796core:ComputerEquipment2022-01-26 13876796core:FurnitureFittings2023-01-31 13876796core:ComputerEquipment2023-01-31 138767962021-02-012022-01-31 iso4217:GBP xbrli:pure
Company Registration No. 13876796 (England and Wales)
LIFE LINE PHARMA LTD Unaudited accounts for the period from 27 January 2022 to 31 January 2023
LIFE LINE PHARMA LTD Unaudited accounts Contents
Page
- 2 -
LIFE LINE PHARMA LTD Company Information for the period from 27 January 2022 to 31 January 2023
Director
Andreea Elena NICHIFORIUC
Company Number
13876796 (England and Wales)
Registered Office
101 WHITECHAPEL ROAD LONDON E1 1DT ENGLAND
Accountants
Khan Islam & Co 117 Whitechapel Road 3rd Floor London London E1 1DT
- 3 -
LIFE LINE PHARMA LTD Statement of financial position as at 31 January 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
5,038 
- 
Current assets
Cash at bank and in hand
366 
- 
Net current assets
366 
- 
Total assets less current liabilities
5,404 
- 
Creditors: amounts falling due after more than one year
(26,800)
- 
Net liabilities
(21,396)
- 
Capital and reserves
Called up share capital
900 
- 
Profit and loss account
(22,296)
- 
Shareholders' funds
(21,396)
- 
For the period ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 21 October 2023 and were signed on its behalf by
Andreea Elena NICHIFORIUC Director Company Registration No. 13876796
- 4 -
LIFE LINE PHARMA LTD Notes to the Accounts for the period from 27 January 2022 to 31 January 2023
1
Statutory information
LIFE LINE PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 13876796. The registered office is 101 WHITECHAPEL ROAD, LONDON, E1 1DT, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
15%
Computer equipment
20%
Government grants
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
4
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 27 January 2022
- 
- 
- 
Additions
3,988 
1,050 
5,038 
At 31 January 2023
3,988 
1,050 
5,038 
Depreciation
At 31 January 2023
- 
- 
- 
Net book value
At 31 January 2023
3,988 
1,050 
5,038 
5
Creditors: amounts falling due after more than one year
2023 
2022 
£ 
£ 
Other creditors
26,800 
- 
- 5 -
LIFE LINE PHARMA LTD Notes to the Accounts for the period from 27 January 2022 to 31 January 2023
6
Average number of employees
During the period the average number of employees was 0 (2022: 0).
- 6 -